ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,333 | -19.2% | 212,111 | +0.8% | 0.00% | – |
| Q2 2023 | $787,383 | +8.4% | 210,530 | -2.9% | 0.00% | – |
| Q1 2023 | $726,193 | +2.1% | 216,774 | +46.5% | 0.00% | – |
| Q4 2022 | $711,538 | +7.2% | 147,929 | +26.8% | 0.00% | – |
| Q3 2022 | $664,000 | -22.8% | 116,640 | -3.7% | 0.00% | – |
| Q2 2022 | $860,000 | +13.5% | 121,132 | +15.3% | 0.00% | – |
| Q1 2022 | $758,000 | +155.2% | 105,018 | +215.4% | 0.00% | – |
| Q4 2021 | $297,000 | -97.3% | 33,293 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $11,134,000 | +2279.1% | 317,579 | +1356.9% | 0.00% | – |
| Q2 2021 | $468,000 | -11.2% | 21,798 | +155.2% | 0.00% | – |
| Q1 2021 | $527,000 | – | 8,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |